Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study

Fig. 2

Survival curves for the ratio of patients with abnormal disease activity indicators and serum MMP-3 between non-progressive and progressive patients. P values were determined by log-rank tests between non-progressive and progressive groups. Pain VAS pain visual analogue scale, 28TJC 28-joint tender joint count, 28SJC 28-joint swollen joint count, PtGA patient global assessment of disease activity, PrGA provider global assessment of disease activity, HAQ health assessment questionnaire, CRP C-reactive protein, ESR erythrocyte sedimentation rate, DAS28 Disease Activity Score 28-joint assessment, SDAI simplified disease activity index, CDAI clinical disease activity index, MMP-3 matrix metalloproteinase-3, RF rheumatoid factor, anti-CCP anti-cyclic citrullinated peptide antibody

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us